{"id":"W211008619","doi":"10.3978/j.issn.2072-1439.2015.01.53","title":"Epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: a decade of progress and hopeful future.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Clovis Oncology","keywords":"Gefitinib; Medicine; Erlotinib; Lung cancer; Epidermal growth factor receptor; Tyrosine kinase; Targeted therapy; Oncology; Cancer research; Internal medicine; Tyrosine-kinase inhibitor; Cancer; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002435921,0.0006501151,0.0008632639,0.0009494197,0.0003907171,0.001692154,0.0006914937,0.002257397,0.0080357],"category_scores_gemma":[0.001722687,0.0001726901,0.000544393,0.0009914048,0.0007783592,0.003966868,0.0008040318,0.003601262,0.003985816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007514833,"about_ca_system_score_gemma":0.002171992,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006909572,"about_ca_topic_score_gemma":0.003517268,"domain_scores_codex":[0.9994876,0.0001166504,0.00005098781,0.00004434158,0.0002180672,0.00008231648],"domain_scores_gemma":[0.9983596,0.0005015777,0.0002261851,0.00004974496,0.000432423,0.0004305366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003463083,0.0001697348,0.0008098181,0.001762919,0.00004491866,0.0002534839,0.00006267993,0.0002130924,0.001067707,0.007325142,0.1549921,0.8329521],"study_design_scores_gemma":[0.0001504428,0.0005885146,0.002049659,0.00228368,0.0001052156,0.001125801,0.0001685609,0.0003179685,0.0004411244,0.006422492,0.9863151,0.00003149357],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008675468,0.9467701,0.0006501766,0.04006114,0.003962179,0.00001814526,0.0001166756,0.00006556545,0.007488534],"genre_scores_gemma":[0.0080003,0.9612612,0.001345212,0.01373533,0.008082221,0.00002518564,0.0002278252,0.00001286453,0.00730982],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0080357,"threshold_uncertainty_score":0.02688205,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01610069568161037,"score_gpt":0.2766067075592,"score_spread":0.2605060118775896,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}